Dividend Investors Should Look Abroad. 3 Stocks From Europe and Japan.
International equities yield more and cost less on average than U.S. stocks. Legrand, RELX, and Astellas Pharma are among the current prospects.
Stay updated with breaking news from 4503 To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
International equities yield more and cost less on average than U.S. stocks. Legrand, RELX, and Astellas Pharma are among the current prospects.
By Ben Glickman Merck & Co., Pfizer and Astellas Pharma have received approval from the U.S. Food and Drug Administration for using Keytruda in...
The Biden administration unveiled a plan to force drugmakers to license generic versions of patented drugs. Stocks barely budged.
By Stephen Nakrosis Astellas Pharma and Seagen said the Food and Drug Administration has accepted for priority review a supplemental biologics license...
Pharmaceutical stocks have generally fallen, partly because of regulatory concerns, but also because high interest rates have made the companies dividends...